Cardio Diagnostics Holdings, has launched its newly redesigned website at CDIO.AI, showcasing its focus on AI-driven precision cardiovascular medicine.

The updated site highlights the company's innovative solutions for the prevention, detection, and management of cardiovascular disease, the leading global cause of death.

The redesign aims to enhance accessibility and navigation for investors, partners, patients, providers, and other key stakeholders.

The revamped website offers improved usability for various groups. Investors can now easily access financial reports, stock information, and corporate governance details. 

Patients will find clear information about Cardio Diagnostics' tests and how to access them. Healthcare providers benefit from streamlined resources for ordering tests and interpreting results.

Additionally, the site features content for payers and employers, explaining the benefits of Cardio Diagnostics’ solutions for managing population health, improving outcomes, and reducing costs. Researchers and pharmaceutical companies can explore collaboration opportunities.

The website highlights several key solutions:

• Epi+Gen CHD Test: An AI-powered test that assesses the three-year risk of coronary heart disease events by analyzing genetic and epigenetic biomarkers, offering a sensitive method for early heart attack risk prediction.
• PrecisionCHD Test: Combines epigenetics, genetics, and AI to detect coronary heart disease and manage stable ischemic heart disease, providing a more effective and accessible diagnostic tool compared to traditional methods.
• Actionable Clinical Intelligence (ACI) Platform: Integrates test results with individual biomarkers and clinical data to deliver actionable insights for clinicians, supporting personalized and data-driven decisions for heart disease management and prevention.

The redesigned website reinforces Cardio Diagnostics’ commitment to advancing cardiovascular care through AI-powered diagnostics and personalized prevention strategies.

The site also includes a resource center with educational materials, scientific publications, and solution documents.

Healthcare providers will find an improved test ordering process, while investors can access a dedicated portal for financial and shareholder information.

 

 

Source: amazonaws.com

Report Abuse